Triple Negative Breast Cancer News and Research

RSS
Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

MAPK4 may play a key role in triple-negative breast cancer

MAPK4 may play a key role in triple-negative breast cancer

New combined therapy shows promising results in treating triple negative breast cancer

New combined therapy shows promising results in treating triple negative breast cancer

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

BioCurate’s new “Proof of Concept” funding to help accelerate research into targeted cancer therapies

BioCurate’s new “Proof of Concept” funding to help accelerate research into targeted cancer therapies

Study finds a significant link between statins and survival rates of triple-negative breast cancer patients

Study finds a significant link between statins and survival rates of triple-negative breast cancer patients

New insights on replication-stress sensitivity in breast cancer cells

New insights on replication-stress sensitivity in breast cancer cells

Biomarker shows potential to predict immunotherapy benefit for breast cancer patients

Biomarker shows potential to predict immunotherapy benefit for breast cancer patients

UTHSC researchers publish new findings on how obesity impacts cancer treatments

UTHSC researchers publish new findings on how obesity impacts cancer treatments

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

Major anti-cancer protein released by neutrophils selectively kills tumor cells

Major anti-cancer protein released by neutrophils selectively kills tumor cells

New class of anti-cancer compounds effectively kills liver and breast cancer cells

New class of anti-cancer compounds effectively kills liver and breast cancer cells

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

Menopausal symptoms in breast cancer patients could be reduced through CBT delivered by nurses

Prolactin hormone acts as a major contributor to breast cancer development, studies find

Prolactin hormone acts as a major contributor to breast cancer development, studies find

Targeted therapy may be of great benefit in early stage breast cancer

Targeted therapy may be of great benefit in early stage breast cancer

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Study: Abundance of iron can drive cancer cell death in neuroblastoma

Study: Abundance of iron can drive cancer cell death in neuroblastoma